OLD Second National Bank of Aurora Purchases 51,833 Shares of The Cooper Companies, Inc. $COO

OLD Second National Bank of Aurora purchased a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the 3rd quarter, Holdings Channel.com reports. The fund purchased 51,833 shares of the medical device company’s stock, valued at approximately $2,930,000.

Other institutional investors have also modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Cooper Companies during the 2nd quarter valued at about $1,077,762,000. Generation Investment Management LLP acquired a new position in shares of Cooper Companies in the 2nd quarter valued at about $356,304,000. Jupiter Topco LLC purchased a new stake in shares of Cooper Companies in the second quarter worth about $305,074,000. Bank of America Corp DE purchased a new stake in shares of Cooper Companies in the second quarter worth about $144,125,000. Finally, Manning & Napier Advisors LLC purchased a new stake in shares of Cooper Companies in the second quarter worth about $107,939,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Stock Up 4.5%

COO opened at $61.65 on Friday. The Cooper Companies, Inc. has a fifty-two week low of $51.01 and a fifty-two week high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.73 and a current ratio of 1.22. The company has a fifty day moving average of $62.09 and a two-hundred day moving average of $65.80. The stock has a market capitalization of $11.72 billion, a price-to-earnings ratio of 21.04, a PEG ratio of 2.40 and a beta of 0.83.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 earnings per share for the quarter, topping analysts’ consensus estimates of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.90%. The business had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.10 billion. During the same quarter in the prior year, the firm posted $0.49 earnings per share. The company’s revenue was up .5% compared to the same quarter last year. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. On average, research analysts expect that The Cooper Companies, Inc. will post 4.53 earnings per share for the current year.

Cooper Companies announced that its board has approved a share buyback plan on Wednesday, September 9th that allows the company to repurchase $3.00 billion in shares. This repurchase authorization allows the medical device company to repurchase up to 22.7% of its shares through open market purchases. Stock repurchase plans are usually a sign that the company’s board believes its shares are undervalued.

Analysts Set New Price Targets

Several analysts recently commented on the company. Wall Street Zen lowered Cooper Companies from a “buy” rating to a “hold” rating in a report on Saturday, September 12th. Citigroup reissued a “neutral” rating and issued a $60.00 price target (down from $80.00) on shares of Cooper Companies in a report on Thursday, September 10th. Robert W. Baird set a $61.00 price objective on Cooper Companies and gave the stock a “neutral” rating in a research report on Thursday, September 10th. Wells Fargo & Company set a $61.00 price objective on Cooper Companies and gave the stock an “equal weight” rating in a research report on Thursday, September 10th. Finally, William Blair cut shares of Cooper Companies from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 10th. Four research analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and an average price target of $68.60.

Insider Activity

In other Cooper Companies news, Director Lawrence Kurzius purchased 10,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 16th. The stock was purchased at an average price of $54.93 per share, for a total transaction of $549,300.00. Following the purchase, the director directly owned 31,099 shares in the company, valued at approximately $1,708,268.07. This trade represents a 47.40% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Walter Rosebrough, Jr. purchased 3,000 shares of Cooper Companies stock in a transaction that occurred on Monday, September 14th. The stock was acquired at an average cost of $54.29 per share, with a total value of $162,870.00. Following the acquisition, the director directly owned 20,000 shares in the company, valued at $1,085,800. This trade represents a 17.65% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 34,701 shares of company stock worth $1,880,039 in the last ninety days. Company insiders own 2.08% of the company’s stock.

About Cooper Companies

CooperCompanies is a global medical device company that develops, manufactures and markets products for vision care and women’s health. The company operates through two primary business segments: CooperVision and CooperSurgical.

CooperVision provides contact lenses and related technologies, including products designed for myopia management, astigmatism, presbyopia and other vision-correction needs. Its portfolio includes daily disposable, reusable and specialty contact lenses sold through eye-care professionals and distributors.

CooperSurgical develops products and services for fertility and women’s health.